Physician profile
Daniel Wilkinson
NPI 1669920526
$246.54
in general payments reported to CMS, 2019-2025
8 companies · $59.73 in 2025
The $59.73 reported for 2025 was more than what a typical Anesthesiologist Assistant provider received nationally (typical 2025 total: $34.52).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $131 · 2023: $55.86 · 2025: $59.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $115.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $60.54 | 2022-2025 | Bridion |
| Becton, Dickinson and Company | $38.98 | 2025 | Hemosphere |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $36.09 | 2022-2023 | Trulance |
| Abbvie INC. | $31.30 | 2022 | |
| Braintree Laboratories, INC. | $23.83 | 2022 | |
| Medtronic, INC. | $19.68 | 2023 | Bis |
| Regeneron Healthcare Solutions, INC. | $19.49 | 2023 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $16.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wilkinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.